Optiscan Imaging Ltd (ASX: OIL) is a global leader in the development, manufacture and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational and pre-clinical applications.
Our unique technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions.
We are driven by delivering digital healthcare solutions giving healthcare providers and researchers high quality, live, microscopic images and associated tools.
Our technology helps facilitate earlier detection and management of disease thus improving patient outcomes and reducing the cost of curative medicine and associated procedures within healthcare systems.
We are united in the common pursuit of revolutionising healthcare with live digital microscopic solutions that enable immediate informed decisions, provide economic efficiencies within health systems and improve patient outcomes.
nextScan is a developer of leading edge technology for the micrographics conversion and document management industry. nextScan’s innovative products are designed and built with a simplicity and functionality that aim to increase user production and lower overall cost for scanning film and fiche. nextScan scanners, combined with nextScan’s revolutionary “Ribbon Scanning” software, provide a complete package that far exceeds the functionality and return on investment when compared with other scanners in the market. nextScan scanners have increased production and lowered cost for customers scanning film and fiche, including MyFamily.com, Preservation Resources, and iArchives. nextScan is privately held and headquartered in Meridian, ID. nextScan develops, manufactures, markets and sells new roll film/microfiche scanners throughout the world. All hardware and software is developed in Meridian where we have both hardware and software engineers. Technical support comes from either Meridian or Dallas, Texas.